Syndax Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 04/08/2026 | Mar 2026Filed 04/08/2026 | Sep 2025Filed 03/11/2025 | Jun 2025Filed 04/08/2026 | Mar 2025Filed 04/08/2026 | Sep 2024Filed 03/11/2025 | Jun 2024Filed 03/11/2025 | Mar 2024Filed 03/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $73 | $65 | $46 | $38 | $20 | $13 | $3.5 | $0 | |
| −$49 | −$43 | −$61 | −$72 | −$85 | −$84 | −$68 | −$72 | |
| −$0.55 | −$0.48 | −$0.70 | −$0.83 | −$0.98 | −$0.98 | −$0.80 | −$0.85 | |
| 89 | 88 | 87 | 86 | 86 | 85 | 85 | 85 |
Trend